Moleculin Biotech (MBRX) Return on Capital Employed [ROCE] (2016 - 2026)
Moleculin Biotech's Return on Capital Employed [ROCE] was -217.35% in Q2 2026, down 27.35 percentage points from -190.00% a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Moleculin Biotech came in at -198.11%, down 78.17 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for four consecutive years, with a five-year change of -116.57 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -119.94% in FY2024 (-47.68 pp), -72.26% in FY2023 (-25.79 pp), -46.47% in FY2022 (-3.08 pp) and -43.39% in FY2021 (+38.15 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2016.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in 1 of the last seven quarters, with an average year-over-year change of -54.64 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2021 (a gain of 57.25 percentage points); the worst was Q1 2025 (a drop of 118.59 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Moleculin Biotech | 2.84 Mn | 2.84 Mn | - | -217.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -217.35% |
| Dec 31, 2025 | -174.50% |
| Sep 30, 2025 | -158.34% |
| Jun 30, 2025 | -190.00% |
| Mar 31, 2025 | -214.58% |
| Dec 31, 2024 | -179.99% |
| Sep 30, 2024 | -153.06% |
| Jun 30, 2024 | -123.43% |
| Mar 31, 2024 | -95.99% |
| Dec 31, 2023 | -92.44% |
| Sep 30, 2023 | -70.40% |
| Jun 30, 2023 | -72.64% |
| Mar 31, 2023 | -64.86% |
| Dec 31, 2022 | -54.16% |
| Sep 30, 2022 | -45.74% |
| Jun 30, 2022 | -36.87% |
| Mar 31, 2022 | -31.27% |
| Dec 31, 2021 | -27.75% |
| Sep 30, 2021 | -24.30% |
| Jun 30, 2021 | -22.77% |
API Access
Moleculin Biotech Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();